ClinicalTrials.govpublic full text
A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab
metastatic melanoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 411385
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.